Luna Innovations

Luna Innovations

LUNA
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40M

Market Cap: $52.0MFounded: 2025Employees: 251-500HQ: Roanoke, United States

Overview

Luna Innovations is a publicly traded technology company with a mission to 'enable the future with fiber' through its proprietary fiber optic sensing and photonic testing systems. The company has achieved a leadership position in industrial and infrastructure monitoring (e.g., aerospace, energy, civil) and is strategically expanding its technology into adjacent high-growth markets, including medical devices and diagnostics. Its strategy combines organic R&D with targeted acquisitions (e.g., Silixa, OptaSense, LIOS, RIO Lasers) to build a comprehensive portfolio of measurement solutions that deliver critical data for safety, security, and efficiency.

Medical DevicesDiagnostics

Technology Platform

Proprietary fiber optic sensing and photonic measurement platform enabling high-precision, distributed monitoring of temperature, strain, acoustics, and shape, with applications from industrial infrastructure to medical devices and diagnostics.

Funding History

2
Total raised:$40M
Series B$30M
Series A$10M

Opportunities

Significant opportunity to leverage core fiber optic sensing and photonic testing technology into the high-growth medical devices and diagnostics sector, enabling next-generation smart implants, surgical tools, and biosensors.
Established OEM partnership model in OCT provides a proven pathway for medical market expansion.

Risk Factors

Revenue is exposed to cyclical capital spending in core industrial markets (energy, aerospace).
Successful penetration of the medical sector carries execution risk due to long development cycles, regulatory hurdles, and the need to build partnerships with risk-averse device OEMs.

Competitive Landscape

Faces competition in sensing from large industrial firms (e.g., Schlumberger, Halliburton) and in photonic testing from giants like Keysight and Viavi. Differentiation is achieved through a broad, integrated technology portfolio, deep application expertise in harsh environments, and a successful OEM partnership model adaptable to medical markets.

Company Timeline

2018Series A

Series A: $10.0M

2020Series B

Series B: $30.0M

2025Founded

Founded in Roanoke, United States